These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 8635038

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.
    Mantovani G, Ghiani M, Curreli L, Maccio A, Massa D, Succu G, Lai P, Massa E, Mudu MC, Astara G.
    Oncol Rep; 1999; 6(2):421-6. PubMed ID: 10023014
    [Abstract] [Full Text] [Related]

  • 6. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
    Quirt I, Robeson C, Lau CY, Kovacs M, Burdette-Radoux S, Dolan S, Tang SC, McKenzie M, Couture F, Canadian Eprex Oncology Study Group.
    J Clin Oncol; 2001 Nov 01; 19(21):4126-34. PubMed ID: 11689580
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 10. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease.
    Provenzano R, Garcia-Mayol L, Suchinda P, Von Hartitzsch B, Woollen SB, Zabaneh R, Fink JC, POWER Study Group.
    Clin Nephrol; 2004 Jun 13; 61(6):392-405. PubMed ID: 15224803
    [Abstract] [Full Text] [Related]

  • 11. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
    Henry DH, Brooks BJ, Case DC, Fishkin E, Jacobson R, Keller AM, Kugler J, Moore J, Silver RT, Storniolo AM, Abels RI, Gordon DS, Nelson R, Larholt K, Bryant E, Rudnick S.
    Cancer J Sci Am; 1995 Jun 13; 1(4):252-60. PubMed ID: 9166485
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
    Abels RI.
    Acta Haematol; 1992 Jun 13; 87 Suppl 1():4-11. PubMed ID: 1574966
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A, Di Liberato L, Daniele F, Battistel V, Colombi L.
    Int J Artif Organs; 1998 Jan 13; 21(1):12-8. PubMed ID: 9554820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.